- Home
- GMGI vs STRO Comparison
GMGI vs STRO Comparison
Compare GMGI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- STRO
- Stock Information
- Founded
- GMGI 2008
- STRO 2003
- Country
- GMGI United States
- STRO United States
- Employees
- GMGI N/A
- STRO N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GMGI Technology
- STRO Health Care
- Exchange
- GMGI Nasdaq
- STRO Nasdaq
- Market Cap
- GMGI 318.8M
- STRO 292.6M
- IPO Year
- GMGI N/A
- STRO 2018
- Fundamental
- Price
- GMGI $2.77
- STRO $2.53
- Analyst Decision
- GMGI
- STRO Strong Buy
- Analyst Count
- GMGI 0
- STRO 7
- Target Price
- GMGI N/A
- STRO $12.14
- AVG Volume (30 Days)
- GMGI 80.0K
- STRO 813.4K
- Earning Date
- GMGI 11-12-2024
- STRO 11-13-2024
- Dividend Yield
- GMGI N/A
- STRO N/A
- EPS Growth
- GMGI N/A
- STRO N/A
- EPS
- GMGI 0.40
- STRO N/A
- Revenue
- GMGI $87,563,172.00
- STRO $160,955,000.00
- Revenue This Year
- GMGI $17.07
- STRO N/A
- Revenue Next Year
- GMGI N/A
- STRO N/A
- P/E Ratio
- GMGI $6.24
- STRO N/A
- Revenue Growth
- GMGI 45.05
- STRO 230.90
- 52 Week Low
- GMGI $2.01
- STRO $2.13
- 52 Week High
- GMGI $6.27
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- GMGI 56.15
- STRO 28.23
- Support Level
- GMGI $2.43
- STRO $2.60
- Resistance Level
- GMGI $2.83
- STRO $4.60
- Average True Range (ATR)
- GMGI 0.27
- STRO 0.36
- MACD
- GMGI -0.01
- STRO -0.16
- Stochastic Oscillator
- GMGI 53.97
- STRO 0.48
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. The company operates in two reportable segments; B2B and B2C. The B2C segment earns majority revenue. The company operates in UK, Asia Pacific and Latin America. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, R Kings Competitions and GM-AG.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.